ASAM Pocket Guidelines and Patient Guide

Stimulant Use Disorder Patient Guide

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1521415

Contents of this Issue

Navigation

Page 10 of 11

11 Pregnant and Postpartum Patients Stimulant use can pose significant risk during pregnancy. It can lead to pregnancy complications as well as miscarriage, premature delivery, fetal growth restriction, maternal death, and fetal death. • Treatment for stimulant use disorder should be initiated as early in the pregnancy as possible. • It is important for the pregnant patient to get regular prenatal care. • Contingency management (CM, described earlier) may be used to encourage prenatal care as well as stimulant use disorder treatment. • Clinicians treating the stimulant use disorder and clinicians providing prenatal care should work together. • Clinicians should ask for patient consent before drug testing and explain the potential consequences of a positive drug test during pregnancy. • Patients may need extra support for their stimulant use disorder after the birth of the baby. • Breastmilk can contain high levels of stimulants. People who are currently using stimulants should not breastfeed. Lesbian, Gay, Bisexual, Transgender, and Questioning (LGBTQ+) Individuals who identify as LGBTQ+ have a high risk of developing a substance use disorder. They are also more likely to have mental health concerns. Some addiction treatment programs offer services designed for LGBTQ+ patients. Some patients may be more comfortable engaging in treatment with others who are LGBTQ+. The clinician should consider the patient's unique experiences and needs when recommending a treatment program.

Articles in this issue

view archives of ASAM Pocket Guidelines and Patient Guide - Stimulant Use Disorder Patient Guide